Gastrointestinal microflora studies in late-onset autism.
By S. Finegold, D. Molitoris, Yuli Song, Chengxu Liu, M. Vaisanen, E. Bolte, M. Mcteague, R. Sandler, H. Wexler, E. Marlowe and 13 more. Clinical Infectious Diseases, 2002
752 citations recorded by the source corpus.
Subfields: Cognitive Neuroscience, Molecular Biology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/8ec85c3df957fc66287d505546107b591a4d3540
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cognitive Neuroscience
In Molecular Biology
In Psychiatry and Mental health
Citations in the corpus
- Shifting the balance: antibiotic effects on host–microbiota mutualism (2011, background): “Associations between extensive antibiotic use and late-onset autism (which develops at 18–24 months of age) suggest that a reassembly of the microbiota may promote the overgrowth of microorganisms that trigger autistic behavioural pattern”
- Normal gut microbiota modulates brain development and behavior (2011, background): “Epidemiological studies have indicated an association between common neurodevelopmental disorders, such as autism and schizophrenia, and microbial pathogen infections during the perinatal period (8, 9).”
- Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified (2013, background): “, 3-methylindole) is interesting particularly in the light of serotonin-function in social interaction, mood disorders, obsessive-compulsive activity [77].”
- The Central Nervous System and the Gut Microbiome (2016, background): “The gut microbiome of ASD patients have increased abundance and diversity of Clostridia species and a general increase in non-spore-forming anaerobes and microaerophilic bacteria compared to neurotypical controls (De Angelis et al., 2013; Finegold et al., 2002, 2010; Parracho et al., 2005).”
- Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics (2017, background): “Its success in treating CDI sparked interest in investigating FMT as a treatment for other medical conditions associated with intestinal dysbiosis, such as ulcerative colitis [9–11], Crohn’s disease (CD) [12–14], irritable bowel syndrome (IBS) [15, 16], and others, including metabolic syndrome [17],”
- Impacts of Gut Bacteria on Human Health and Diseases (2015, background): “significant numbers of non-spore-forming anaerobes and microaerophilic bacteria were found in gastric and duodenal specimens from children with autism, while such bacteria are totally absent in the gut and duodenum from control children [121].”
- Gastrointestinal flora and gastrointestinal status in children with autism -- comparisons to typical children and correlation with autism severity (2011, background): “Finegold et al. 2002 [11] studied fecal samples from 13 children with late-onset autism and 8 controls.”
- The role of microbiome in central nervous system disorders (2013, positive): “Indeed, two ensuing human gut microbiome studies illustrated a greater number of species under the Clostridium genus present in fecal samples of autistic children (Finegold et al., 2002; Parracho et al., 2005).”
- Intestinal microbiota in human health and disease: the impact of probiotics (2011, background): “The number of Clostridium species found in the stools of children with autism was greater than in the stools of control children, specifically of the C. histolyticum group (Clostridium clusters I and II) (Finegold et al. 2002; Parracho et al. 2005).”
- Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. (2005, background): “Previous cultivation and PCR-based studies (Finegold et al., 2002; Song et al., 2004) have also shown distinctive clostridial populations in autistic children compared with healthy controls.”